StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)

Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –

Incyte cash

Cash and short-term investments held at the end of each period.

Incyte's cash was $3.28B at Sep 30, 2026. For fiscal 2025 it was $3.10B, up 83.4% from the year before. Over ten years it grew 15.7% a year on average. The highest annual figure on record is $3.66B in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.10B+83.4%
FY2024Dec 31, 2024$1.69B-53.8%
FY2023Dec 31, 2023$3.66B+12.9%
FY2022Dec 31, 2022$3.24B+37.9%
FY2021Dec 31, 2021$2.35B+30.3%
FY2020Dec 31, 2020$1.80B-14.9%
FY2019Dec 31, 2019$2.12B+47.2%
FY2018Dec 31, 2018$1.44B+23.0%
FY2017Dec 31, 2017$1.17B+44.6%
FY2016Dec 31, 2016$809.43M+12.0%
FY2015Dec 31, 2015$722.69M+20.4%
FY2014Dec 31, 2014$600.26M+17.9%
FY2013Dec 31, 2013$509.00M+122.8%
FY2012Dec 31, 2012$228.42M-17.7%
FY2011Dec 31, 2011$277.59M-34.6%
FY2010Dec 31, 2010$424.17M-5.7%
FY2009Dec 31, 2009$449.82M+151.6%
FY2008Dec 31, 2008$178.77M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.28B+33.3%
Q2 FY2026Jun 30, 2026$3.98B+103.5%
Q1 FY2026Mar 31, 2026$3.46B+78.1%
Q4 FY2025Dec 31, 2025$3.10B+83.4%
Q3 FY2025Sep 30, 2025$2.46B+38.6%
Q2 FY2025Jun 30, 2025$1.96B+34.8%
Q1 FY2025Mar 31, 2025$1.94B-49.6%
Q4 FY2024Dec 31, 2024$1.69B-53.8%
Q3 FY2024Sep 30, 2024$1.77B-49.6%
Q2 FY2024Jun 30, 2024$1.45B-57.6%
Q1 FY2024Mar 31, 2024$3.85B+23.7%
Q4 FY2023Dec 31, 2023$3.66B+12.9%
Q3 FY2023Sep 30, 2023$3.52B+18.1%
Q2 FY2023Jun 30, 2023$3.43B+25.7%
Q1 FY2023Mar 31, 2023$3.11B+22.3%
Q4 FY2022Dec 31, 2022$3.24B+37.9%
Q3 FY2022Sep 30, 2022$2.98B+30.3%
Q2 FY2022Jun 30, 2022$2.72B+30.8%
Q1 FY2022Mar 31, 2022$2.55B+29.6%
Q4 FY2021Dec 31, 2021$2.35B+30.3%
Q3 FY2021Sep 30, 2021$2.29B+31.6%
Q2 FY2021Jun 30, 2021$2.08B+30.8%
Q1 FY2021Mar 31, 2021$1.96B+50.5%
Q4 FY2020Dec 31, 2020$1.80B-14.9%
Q3 FY2020Sep 30, 2020$1.74B-12.6%
Q2 FY2020Jun 30, 2020$1.59B-6.2%
Q1 FY2020Mar 31, 2020$1.31B-17.5%
Q4 FY2019Dec 31, 2019$2.12B+47.2%
Q3 FY2019Sep 30, 2019$1.99B+44.4%
Q2 FY2019Jun 30, 2019$1.70B+41.5%
Q1 FY2019Mar 31, 2019$1.58B+35.0%
Q4 FY2018Dec 31, 2018$1.44B+23.0%
Q3 FY2018Sep 30, 2018$1.38B+7.3%
Q2 FY2018Jun 30, 2018$1.20B+96.8%
Q1 FY2018Mar 31, 2018$1.17B+128.5%
Q4 FY2017Dec 31, 2017$1.17B+44.6%
Q3 FY2017Sep 30, 2017$1.28B–
Q2 FY2017Jun 30, 2017$609.55M–
Q1 FY2017Mar 31, 2017$512.86M–
Q4 FY2016Dec 31, 2016$809.43M–

More Incyte figures

See a number that looks wrong?